Development and initial validation of a heart disease knowledge questionnaire for people with rheumatoid arthritis

Holly John1, Gareth J Treharne, Elizabeth D Hale

  • 1Department of Rheumatology, Dudley Group of Hospitals NHS Foundation Trust, Dudley, UK. Holly.John@dgoh.nhs.uk

Insights

Two parallel versions of the Heart Disease Fact Questionnaire-Rheumatoid Arthritis (HDFQ-RA) were developed and validated. These reliable and valid tools measure cardiovascular disease knowledge in rheumatoid arthritis patients.

Area of Science:

  • Rheumatology
  • Cardiovascular Health
  • Psychometrics

Background:

  • Rheumatoid arthritis (RA) patients face increased cardiovascular disease (CVD) risk.
  • Assessing CVD knowledge in RA patients is crucial for targeted interventions.
  • Existing tools may not adequately address RA-specific concerns regarding CVD.

Purpose of the Study:

  • To develop and validate two parallel forms of the Heart Disease Fact Questionnaire-Rheumatoid Arthritis (HDFQ-RA).
  • To create an RA-specific instrument for measuring CVD knowledge.
  • To ensure the reliability and validity of the new HDFQ-RA forms.

Main Methods:

  • Modified the original HDFQ with RA-specific questions.
  • Utilized cognitive interviewing and piloting to create two parallel questionnaires.
  • Conducted psychometric validation with 130 RA patients, including test-retest reliability and known groups comparison.

Main Results:

  • Established parallel form reliability and test-retest stability for both HDFQ-RA versions (median score 9/13).
  • Achieved Kuder-Richardson-20 reliability coefficients of 0.65 and 0.67.
  • Demonstrated higher scores in patients who self-educated on heart disease or used CVD medications, supporting construct validity.

Conclusions:

  • The two parallel HDFQ-RA forms are equivalent, reliable, and valid measures of CVD knowledge.
  • The HDFQ-RA is suitable for clinical and research settings, including evaluating educational interventions and tracking participant progress.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...